Evidence-based psychotherapies for depression

Journal of Occupational and Environmental Medicine

Volumn 50, Issue 4, 2008, Pages 437-440

  Markowitz, John C ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; NEFAZODONE;

ALTERNATIVE MEDICINE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; DEPRESSION; EVIDENCE BASED MEDICINE; GROUP THERAPY; HUMAN; MEDICAL LITERATURE; PSYCHOTHERAPY; REVIEW; VALIDATION PROCESS; WORKPLACE;

EID: 42049084666     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e318168f76e     Document Type: Article

References (35)

1. Murray CJL, Lopez AD. Alternative visions of the future: projecting mortality and disability, 1990-2020. In: Murray CJL, Lopez AD, eds. The Global Burden of Disease. Cambridge (Massachusetts): Harvard University Press; 1996:325-397.
2. Greenberg PE, Kessler RC, Birnbaum HG, et al. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465-1475.
3. Stewart WF, Ricci JA, Chee E, Hahn SR, Morganstein D. Cost of lost productive work time among US workers with depression. JAMA. 2003;289:3135-3144.
4. Adler DA, McLaughlin TJ, Rogers WH, Chang H, Lapitsky L, Lerner D. Job performance deficits due to depression. Am J Psychiatry. 2006;163:1569-1576.
5. Berndt ER, Finkelstein SN, Greenberg PE, et al. Workplace performance effects from chronic depression and its treatment. J Health Econ. 1998;17:511-535.
6. Broadhead WE, Blazer DG, George LK, Tse CK. Depression, disability days, and days lost from work in a prospective epidemiologic study. JAMA. 1990;264:2524-2528.
7. Kessler RC, Barber C, Birnbaum HG, et al. Depression in the workplace: effects on short-term disability. Health Aff. 1999;18:163-171.
8. Wang PS, Berland P, Kessler RC. Recent care for common mental disorders in the United States: prevalence and conformance with evidence-based recommendations. J Gen Intern Med. 2000;15:284-292.
9. Young AS, Klap R, Sherbourne CD, Wells KB. The quality of care for depression and anxiety disorders in the United States. Arch Gen Psychiatry. 2001;58:55-61.
10. Karasu TB, Docherty JP, Gelenberg A, Kupfer DJ, Merriam AE, Shadoan R. Practice guideline for major depressive disorder in adults. Am J Psychiatry. 1993;150(suppl):1-26.
11. Depression Guideline Panel: Clinical Practice Guideline. Depression in Primary Care: Vol. 1-4. Rockville, MD, U.S. Department of Health and Human Services, Agency for Health Care Policy and Research; 1993. AHCPR Publications No. 93-0550-0553.
12. Hollon SD, Thase ME, Markowitz JC. Treatment and prevention of depression. Psychol Sci Public Interest. 2002;3:39-77.
13. Frank E, Kupfer DJ, Perel JM, et al. Three-year outcomes for maintenance therapies in recurrent depression. Arch Gen Psychiatry. 1990;47:1093-1099.
14. Reynolds CF III, Frank E, Perel JM, et al. Nortriptyline and interpersonal psychotherapy as maintenance therapies for recurrent major depression: a randomized controlled trial in patients older than fifty-nine years. JAMA. 1999;281:39-45.
15. Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs medications in moderate to severe depression. Arch Gen Psychiatry. 2005;62:417-422.
16. Rush AJ, Thase ME. Psychotherapies for depressive disorders: a review. In: Maj M, Sartorius N, eds. Depressive Disorders: WPA Series Evidence and Experience in Psychiatry. Chichester: John Wiley & Sons; 1999:161-206.
17. Keller MB, McCullough JP, Klein DN, et al. The acute treatment of chronic major depression: a comparison of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. N Eng J Med. 2000;342:1462-1470.
18. Blom MB, Jonker K, Dusseldorp E, et al. Combination treatment for acute depression is superior only when psychotherapy is added to medication. Psychother Psychosom. 2007;76:289-297.
19. Beck AT, Rush AJ, Shaw BF, Emery G. Cognitive Therapy of Depression. New York: Guilford; 1979.
20. DeRubeis RJ, Hollon SD, Amsterdam JD, et al. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62:409-416.
21. Weissman MM, Markowitz JC, Klerman GL. Comprehensive Guide to Interpersonal Psychotherapy. New York: Basic Books; 2000.
22. Weissman MM, Markowitz JC, Klerman GL. Clinician's Quick Guide to Interpersonal Psychotherapy. New York: Oxford University Press; 2007.
23. Weissman MM, Prusoff BA, DiMascio A, Neu C, Goklaney M, Klerman GL. The efficacy of drugs and psychotherapy in the treatment of acute depressive episodes. Am J Psychiatry. 1979;136:555-558.
24. Elkin I, Shea MT, Watkins JT, et al. National Institute of Mental Health treatment of depression collaborative research program: General effectiveness of treatments. Arch Gen Psychiatry. 1989;46:971-982.
25. Martell CR, Addis ME, Jacobson NS. Depression in Context: Strategies for Guided Action. New York: W.W. Norton; 2001.
26. Dimidjian S, Hollon SD, Dobson KS, et al. Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression. J Consult Clin Psychology. 2006;74:658-670.
27. McCullough JP Jr. Treatment for Chronic Depression: Cognitive Behavioral Analysis System of Psychotherapy. New York: Guilford Press; 2000.
28. Cuijpers P, van Straten A, Warmerdam L. Problem solving therapies for depression: a meta-analysis. Eur Psychiatry. 2007;22:9-15.
29. Wright JH, Wright AS, Albano AM, et al. Computer-assisted cognitive therapy for depression: maintaining efficacy while reducing therapist time. Am J Psychiatry. 2005;162:1158-1164.
30. Sotsky SM, Glass DR, Shea MT, et al. Patient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH treatment of depression collaborative research program. Am J Psychiatry. 1991;148:997-1008.
31. Weissman MM, Verdeli H, Gameroff MJ, et al. National survey of psychotherapy training in psychiatry, psychology, and social work. Arch Gen Psychiatry. 2006;63:925-934.
32. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;25:56-62.
33. Beck AT. Depression Inventory. Philadelphia: Center for Cognitive Therapy; 1978.
34. Browne G, Steiner M, Roberts J, et al. Sertraline and/or interpersonal psychotherapy for patients with dysthymic disorder in primary care: 6 month comparison with longitudinal 2 year follow-up of effectiveness and costs. J Affect Disord. 2002;317-330.
35. Myhr G, Payne K. Cost-effectiveness of cognitive-behavioural therapy for mental disorders: implications for public health care funding policy in Canada. Can J Psychiatry. 2006;51:662-670.